Real-World Characteristics and Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) and HER2 Mutations

被引：0
|
作者：
Bath, Christina [1 ]
Le, Xiuning [2 ]
Lovly, Christine M. [3 ]
Patil, Tejas [4 ]
Maruti, Sonia S. [5 ]
Stanhope, Stephen A. [5 ]
Herbert, Stephan [6 ]
Nagasaka, Misako [7 ,8 ,9 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Univ Colorado, Sch Med, Aurora, CO USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[7] Univ Calif Irvine, Sch Med, Orange, CA USA
[8] Chao Family Comprehens Canc Ctr, Orange, CA USA
[9] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.115
引用
收藏
页码：E49 / E50
页数：2
相关论文
共 50 条
  • [21] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [22] Real-World Outcomes Among Advanced Non-Small Cell Lung Cancer Patients Re-Treated with Immunotherapy in the US
    Spira, A.
    Monnette, A.
    Wentworth, C.
    Doan, J.
    Chang, C.
    Hartman, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S189 - S190
  • [23] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [24] Observing patients with advanced non-small cell lung cancer (NSCLC): An overview of real world treatments and outcomes in Europe
    Bischoff, H. G.
    Anderson, H.
    van den Borne, B.
    Langer, F.
    Leschinger, M. I.
    Moneley, C.
    Pimentel, F.
    Riska, H.
    Thatcher, N.
    Thomas, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Real-world outcomes of patients with advanced non-small cell lung cancer and driver mutations treated with frontline immunotherapy and/or chemotherapy.
    Muthusamy, Bharathi
    Pennell, Nathan A.
    Belli, Andrew J.
    Hansen, Eric
    Devincenzo, Victoria
    Shankaranarayana, Shubha
    He, Ming
    Wang, Ching-Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer
    Shi Bu
    Rui Wang
    Yunjian Pan
    Su Yu
    Xuxia Shen
    Yuan Li
    Yihua Sun
    Haiquan Chen
    Annals of Surgical Oncology, 2017, 24 : 291 - 297
  • [27] Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer
    Bu, Shi
    Wang, Rui
    Pan, Yunjian
    Yu, Su
    Shen, Xuxia
    Li, Yuan
    Sun, Yihua
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (01) : 291 - 297
  • [28] Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
    Assie, J.
    Cotte, F.
    Levra, M. Giaj
    Calvet, C.
    Jolivel, R.
    Jouaneton, B.
    Gaudin, A.
    Grumberg, V.
    Chouaid, C.
    Corre, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S708 - S708
  • [29] Clinical characteristics, co-mutations and outcomes of advanced non-small cell lung cancer (NSCLC) patients with KRAS mutations.
    Muthiah, Arun
    Chudasama, Rani
    Olszewski, Adam J.
    Saiganesh, Harish
    Kurt, Habibe
    Mingrino, Jennifer
    Garcia-Moliner, Maria
    Azzoli, Christopher G.
    Khurshid, Humera
    Birnbaum, Ariel E.
    Khan, Hina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Hozefa A. Divan
    Marisa A. Bittoni
    Ashok Krishna
    David P. Carbone
    BMC Cancer, 24
12345